Core Viewpoint - The company expects to achieve a profit of no less than 30 million HKD for the six months ending June 30, 2025, compared to a profit of approximately 74.2 million HKD for the six months ending June 30, 2024, primarily due to global trade fluctuations caused by U.S. tariff policies [1] Financial Performance - The profit forecast for the upcoming period is significantly lower than the previous period, indicating a decline in financial performance [1] - The company reported a profit of approximately 74.2 million HKD for the six months ending June 30, 2024 [1] Market Conditions - The company faces challenges in the Chinese market due to economic weakness and low consumer sentiment, leading to a downward trend [1] - Intense price competition in the Chinese market has contributed to the unfavorable market conditions [1] Operational Strategy - The company is leveraging its global presence in China, the U.S., and Vietnam to flexibly adjust production capacity according to market demands [1] - The company plans to closely monitor the situation and allocate resources to explore high-growth potential businesses while reviewing costs [1] - Cost reduction measures will be implemented in production and logistics to mitigate the impact of current market conditions [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部 份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 本公司正在落實本集團於本期間之未經審核綜合財務業績。本公佈所載資料僅為董 事會根據其目前可得資料作出之初步評估，有關資料未經本公司核數師或審核委員 會審核或審閱。股東及本公司有意投資者務請細閱本公司於本期間之中期業績公 佈，預期有關公佈將於2025年8月底前刊發。 股東及本公司有意投資者於買賣本公司股份時，務須審慎行事。 承董事會命 盛諾集團有限公司 主席 Sinomax Group Limited 盛諾集團有限公 司 （根據開曼群島法例註冊成立的有限公司） （股份代號：1418） 盈利預警 本公佈乃由盛諾集團有限公司（「本公司」，連同其附屬公司統稱「本集團」）根據香港 聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2)(a)條及香港法例第571章 證券及期貨條例第XIVA部項下內幕消息條文（定義見上市規則）而作出。 本公司董事會（「董事會」）謹此知會本公司股東（「股東」）及有意投資者，根據 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部 份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Sinomax Group Limited 須予披露交易 收購知識產權 盛諾集團有限公 司 （根據開曼群島法例註冊成立的有限公司） （股份代號：1418） 補充公佈 茲提述盛諾集團有限公司（「本公司」，連同其附屬公司統稱「本集團」）日期為2025年 7月8日之公佈，內容有關IP收購協議（「該公佈」）。除另有指明者外，本公佈所用詞彙 與該公佈所界定者具有相同涵義。 除該公佈所載資料外，本公司謹此向股東及公眾人士提供以下有關IP收購協議之補 充資料： 購買價的釐定基準 根據許可協議，本集團須每季度向Kimberly支付最少200,000美元（相當於約1,560,000 港元）的版稅，每年800,000美元（相當於約6,240,000港元）。供說明之用，五年將為 4,000,000美元（相當於約31,200,000港元），不包括根據銷售表現而可能增加或額外 的版稅。本集團預期將繼續利用品牌至少八至十年，此支持以 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 盛諾集團有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01418 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | 本月底法定/註冊股本總額： HKD 1,000,0 ...

格隆汇7月31日丨盛诺集团(01418.HK)公布，公司将于2025年8月29日（星期二）举行董事会会议，藉以 （其中包括）批准公司及其附属公司截至2025年6月30日止六个月的未经审核中期业绩及刊发其公告， 以及考虑派发中期股息（如有）及处理其他事宜（如有）。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部 份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 林志凡 香港，二零二五年七月三十一日 於本公佈日期，本公司非執行董事為林志凡先生（董事會主席）；本公司執行董事為 張棟先生（總裁）、陳楓先生、林錦祥先生（首席財務官及公司秘書）及林斐雯女士；本 公司獨立非執行董事為王志強先生、張傑先生及張華強博士。 董事會召開日期 盛諾集團有限公司（「本公司」）董事會（「董事會」）謹此公佈，本公司將於二零二五年 八月十九日（星期二）舉行董事會會議，藉以（其中包括）批准本公司及其附屬公司截 至二零二五年六月三十日止六個月之未經審核中期業績及刊發其公告，以及考慮派 發中期股息（如有）及處理其他事宜（如有）。 承董事會命 盛諾集團有限公司 主席 Sinomax Group Limited 盛諾集團有限公 司 （根據開曼群島法例註冊成立的有限公司） （股份代號：1418） ...

Core Viewpoint - Sinomax USA, a wholly-owned subsidiary of the company, has entered into an IP acquisition agreement with Kimberly for a purchase price of $4.6 million, which is approximately HKD 35.88 million [1][2] Group 1 - The acquisition includes the "VIBE" brand's trademarks, copyrights, and all other related intellectual property, enhancing the company's product range and market share [1][2] - The VIBE brand is a well-known American brand with about eight years of history and high brand recognition in its market segment [2] - Since November 2022, Sinomax USA has been using the acquired IP under a licensing agreement, making the acquisition a cost-effective and low-risk opportunity for the company to transition from a licensee to an owner [2] Group 2 - The acquisition will provide the company with greater flexibility in brand positioning, marketing, and expansion strategies [2] - It offers strategic flexibility and the potential to realize brand value, especially in markets outside the current licensing agreement coverage [2]

Financial Performance - Revenue for 2024 increased to HK$4,091,144, representing a growth of approximately 13.4% compared to HK$3,608,894 in 2023[16] - Profit for the year amounted to HK$162,649, an increase from HK$80,502 in 2023, reflecting a significant growth in profitability[16] - Gross profit margin improved slightly to 25.6% in 2024 from 25.5% in 2023[18] - The company achieved a net profit margin of 4.0%, up from 2.2% in the previous year[18] - The Group achieved a revenue increase of approximately HK$482.3 million or 13.4%, reaching approximately HK$4,091.1 million for the fiscal year 2024[33] - Profit for the Reporting Period increased by approximately HK$82.1 million or 102.0%, totaling approximately HK$162.6 million compared to approximately HK$80.5 million for FY2023[43] - Gross profit increased by approximately HK$127.3 million or 13.8%, amounting to approximately HK$1,047.0 million, with a gross profit margin of approximately 25.6%[39] - Sales in the North American market increased by approximately 17.3%, while sales in the China market grew by approximately 10.0%[36] Financial Position - Total assets increased to HK$2,556,986, compared to HK$2,406,144 in 2023, indicating a solid financial position[16] - As of December 31, 2024, the Group had net current assets of approximately HK$370.2 million, an increase from approximately HK$339.4 million as of December 31, 2023[47] - The current ratio improved slightly to 128.6% from 126.8% in 2023, reflecting better liquidity management[18] - The current ratio improved to 128.6% in 2024 from 126.8% in 2023, while the quick ratio increased to 91.8% from 86.6%[55] - The gearing ratio decreased to 40.1% in 2024 from 48.1% in 2023, and the debt to equity ratio slightly improved to 13.9% from 14.4%[55] - Bank balance and cash decreased by approximately HK$47.5 million or 15.3%, totaling approximately HK$262.4 million as of December 31, 2024[47] Dividend and Payout Policy - The payout ratio decreased to 10.7% from 37.0% in 2023, indicating a shift in dividend policy[18] - The Board recommends a final dividend of HK$1.3 cents per ordinary share, totaling approximately HK$22,750,000, subject to Shareholder approval at the AGM on May 16, 2025[102] - The Group's reserves available for distribution to Shareholders amounted to approximately HK$471.5 million as of December 31, 2024, down from approximately HK$516.7 million as of December 31, 2023[112] Strategic Initiatives - The company plans to explore higher growth potential businesses, particularly in the US and European markets[21] - The company aims to diversify its customer base and maintain its position in the visco-elastic health and wellness products market[22] - The company plans to focus on expanding its presence in the U.S. and Europe, with ongoing sales projects expected to drive growth in the Mattress-in-a-box segment[60] - The group will implement various cost-cutting measures across production and logistics to enhance efficiency and manage expenses[59] Awards and Recognition - Sinomax USA was recognized as a Top Foam Technology Solution Provider of 2024, highlighting its innovation in foam-based bedding products[23] - Sinomax USA was recognized as "Company of the Year" by the 2024 BIG Awards for Business, highlighting its commitment to sustainable innovation[27] Management and Governance - The company has over 31 years of experience in accounting and auditing, with Mr. Lam serving as the Chief Financial Officer since August 2013[78] - Mr. Cheung is responsible for the overall management and daily operations of the Group, having joined in 2003 and appointed to the Board in June 2012[74] - The Group's management team includes a mix of family relations, enhancing internal collaboration and strategic alignment[74][75][79] - The company emphasizes the importance of corporate governance, with Mr. Wong serving as the chairman of the audit committee[82] - The executive team is composed of individuals with diverse educational backgrounds, including degrees in business administration and engineering[78][79] - The Group's strategic direction is influenced by its founding members, ensuring continuity in its business strategy[74][79] - The company has a strong governance structure with independent directors serving on multiple committees including audit, remuneration, and corporate governance[88] - The board includes members with extensive experience in their respective fields, enhancing the company's strategic planning and operational oversight[88] - The management team is committed to maintaining high standards of corporate governance and operational excellence[88] Employee and Operational Metrics - The total employee headcount increased to 3,333 in 2024 from 2,846 in 2023, with total staff costs rising to approximately HK$639.1 million from HK$523.6 million[66] - Administrative expenses increased by approximately HK$17.2 million or 6.9%, reaching approximately HK$267.4 million, primarily due to increased staff costs[42] Connected Transactions - The company has ongoing connected transactions with Gu Jia Household Co., Limited, which is a substantial shareholder of a subsidiary[157] - The procurement agreement with Gu Jia Household for the sale of polyurethane foams was revised on November 1, 2017, and governs transactions between the companies[158] - The total sales to Gu Jia Household under the Revised 2021-2023 Gu Jia Procurement Agreement for the year ended December 31, 2023, amounted to approximately RMB283.8 million (approximately HK$313.4 million)[172] - The annual caps for the Revised 2021-2023 Gu Jia Procurement Agreement are set at RMB440.0 million for 2021, RMB520.0 million for 2022, and RMB630.0 million for 2023[172] - The independent non-executive Directors confirmed that the continuing connected transactions have been entered into in accordance with the Listing Rules[175] - The auditor issued unqualified letters regarding the Group's continuing connected transactions, confirming compliance with the relevant standards[175] Lease Agreements - Dongguan Sinohome entered into a lease agreement for the Dongguan Premises at a monthly rental of approximately RMB695,000 for a term of slightly more than two years starting from December 2, 2013[180] - The monthly rental for the Renewal Dongguan Lease Agreement, effective from January 1, 2016, was approximately RMB1.3 million for a three-year term[181] - The monthly rental for the 2023 Dongguan Lease Agreement was approximately RMB720,000 for a one-year term starting January 1, 2023[186] - The monthly rental for the 2024 Dongguan Lease Agreement is approximately RMB750,000 for a one-year term starting January 1, 2024[187] - The rental agreements with Zhejiang Puruimei indicate a consistent strategy of securing long-term leases for operational facilities to support business growth[198] - The lease agreements reflect a commitment to maintaining operational capacity and flexibility in the Chinese market[198]

Financial Performance - Revenue for the year increased by approximately HKD 482.3 million or 13.4% to approximately HKD 4,091.1 million compared to HKD 3,608.9 million in the fiscal year 2023[3] - Gross profit rose by approximately HKD 127.3 million or 13.8% to approximately HKD 1,047.0 million from HKD 919.7 million in the previous fiscal year[3] - Profit for the year increased by approximately HKD 82.1 million or 102.0% to approximately HKD 162.6 million compared to HKD 80.5 million in the fiscal year 2023[3] - Basic and diluted earnings per share increased to 7.89 HKD cents from 3.58 HKD cents in the previous year[5] - Total comprehensive income for the year amounted to HKD 124.2 million, up from HKD 53.7 million in the previous year[5] Dividends - The board recommended a final dividend of 1.3 HKD cents per share, consistent with the previous year's final dividend[3] - The interim dividend declared was HKD 0.01 per share, totaling approximately HKD 17,500,000, while the proposed final dividend is HKD 0.013 per share, amounting to approximately HKD 22,750,000[50] - The board of directors proposed a final dividend of HKD 0.013 per ordinary share, amounting to approximately HKD 22,750,000, pending approval at the annual general meeting on May 16, 2025[99] Assets and Liabilities - Non-current assets totaled HKD 891.9 million, an increase from HKD 799.6 million in the previous year[7] - Current assets increased to HKD 1,665.1 million from HKD 1,606.5 million in the previous year[7] - Total liabilities rose to HKD 1,557.2 million from HKD 1,487.7 million in the previous year[8] - Total equity increased to HKD 999.8 million from HKD 918.5 million in the previous year[8] Market Performance - Sales of health and home products amounted to HKD 2,728,901,000, up from HKD 2,365,437,000, representing a growth of 15.4%[24] - The North American market generated revenue of HKD 1,624,615,000, a 17.3% increase compared to HKD 1,384,678,000 in the previous year[22] - The European and other overseas markets contributed HKD 717,739,000, reflecting a growth of 13.1% from HKD 634,582,000[22] Expenses - The cost of sales for the year was HKD 3,044,162,000, resulting in a gross profit of HKD 1,046,982,000[22] - Research and development expenses increased to HKD 87,966,000 from HKD 80,178,000, indicating a rise of 9.9%[22] - The total cost of sales, selling and distribution expenses, administrative expenses, and R&D costs amounted to HKD 3,893,806,000 in 2024, up from HKD 3,477,910,000 in 2023, representing an increase of approximately 12%[35] - Marketing expenses increased to HKD 138,759,000 in 2024 from HKD 127,154,000 in 2023, indicating an increase of about 9%[35] Taxation - The company's income tax expense for 2024 was HKD 36,846,000, a decrease from HKD 42,110,000 in 2023, reflecting a reduction of approximately 12.5%[47] - The company reported a decrease in Hong Kong profits tax from HKD 7,521,000 in 2023 to HKD 506,000 in 2024, a significant reduction of approximately 93%[47] Joint Ventures and Investments - The company acquired a 45% stake in M DK Holdings ApS for approximately HKD 51,170,000, with an associated share of profit from the joint venture amounting to HKD 5,025,000[37] - The income from the joint venture for the period from October 14, 2024, to December 31, 2024, was HKD 303,965,000, with a total profit and comprehensive income of HKD 11,165,000[42] - The company has invested approximately HKD 51.0 million in a European joint venture, yielding a significant return of approximately HKD 5.02 million from the joint venture's profit[88] Receivables and Payables - Trade receivables increased to HKD 649,369,000 in 2024 from HKD 573,533,000 in 2023, with a net trade receivable of HKD 626,007,000 after deducting credit loss provisions[53] - The total amount of trade and other receivables rose to HKD 807,095,000 in 2024, up from HKD 706,019,000 in 2023, indicating a growth of approximately 14.3%[53] - The company reported trade payables of HKD 487,035,000 in 2024, an increase from HKD 452,711,000 in 2023, reflecting a growth of about 7.6%[63] - The company’s total liabilities for trade and other payables reached HKD 743,860,000 in 2024, an increase from HKD 676,264,000 in 2023, indicating a growth of approximately 10%[63] Employee and Operational Metrics - The total number of employees increased to 3,333, with total employee costs rising to approximately HKD 639.1 million, compared to HKD 523.6 million in the previous fiscal year[92] - Capital expenditures for the reporting period amounted to approximately HKD 65.8 million, up from HKD 62.2 million in the previous fiscal year, primarily for the purchase of equipment and machinery[81] Financial Health - The company's liquidity ratios improved, with the current ratio at 128.6% and the quick ratio at 91.8% as of December 31, 2024[82] - The company's expected credit loss for overdue trade receivables was HKD 122,599,000 in 2024, down from HKD 183,846,000 in 2023, reflecting improved management of overdue accounts[59] Accounting and Reporting - The company anticipates no significant impact from the adoption of new accounting standards effective in 2025 and 2026[18] - The independent auditor, PwC, confirmed that the financial statements for the reporting period are consistent with the audited consolidated financial statements[97] - The annual performance report and 2024 annual report will be published on the Hong Kong Stock Exchange and the company's website[103]

Revenue and Sales Performance - Revenue for the six-month period ended June 30, 2024, increased by approximately HK$403.2 million or approximately 25.2% to approximately HK$2,002.8 million compared to approximately HK$1,599.6 million for the corresponding period last year[27]. - Sales in the China market increased by approximately 20.6% for the Reporting Period, primarily due to an increase in orders from major customers[28]. - North American market sales increased by approximately 36.9% for the Reporting Period, attributed to an increase in market share[29]. - Sales in Europe and other overseas markets recorded an increase of approximately 12.6% for the Reporting Period, mainly due to increased sales to customers in Vietnam[29]. - The total revenue breakdown by market shows China at HK$863.6 million, North America at HK$813.6 million, and Europe and other overseas markets at HK$325.6 million for the Reporting Period[28]. - Revenue from the China market was HK$863,566,000, reflecting a 20.6% increase from HK$716,016,000 in the prior year[114]. - The North American market generated revenue of HK$813,581,000, up 37.0% from HK$594,351,000 in the same period last year[114]. - Sales of health and household products amounted to HK$1,341,486,000 for the six months ended June 30, 2024, up 26.4% from HK$1,061,249,000 in 2023[113]. - Sales of polyurethane foam increased to HK$661,289,000, a rise of 22.8% from HK$538,337,000 in the previous year[113]. Profitability and Financial Performance - Gross profit increased by approximately HK$140.4 million or approximately 38.3% to approximately HK$507.3 million during the Reporting Period, compared to approximately HK$366.9 million for the corresponding period last year[30]. - Profit for the period increased by approximately HK$51.8 million or 231.8% to approximately HK$74.2 million compared to approximately HK$22.4 million for the corresponding period last year[32]. - Operating profit increased significantly to HK$115,842,000, compared to HK$49,460,000 in the prior year, marking a 134.0% rise[84]. - Profit for the period attributable to equity owners of the Company was HK$62,096,000, a substantial increase from HK$18,637,000, reflecting a growth of 233.5%[83]. - Total comprehensive income for the period was HK$54,229,000, compared to a loss of HK$10,010,000 in the previous year[87]. - The Group's overall performance reflects a strong recovery and growth trajectory in key markets, indicating effective strategic initiatives[27]. Expenses and Cost Management - Selling and distribution costs increased by approximately HK$44.0 million or 21.1% to approximately HK$253.0 million compared to HK$209.0 million for the six-month period ended 30 June 2023[32]. - Administrative expenses increased by approximately HK$32.8 million or 35.9% to approximately HK$124.2 million compared to HK$91.4 million for the six-month period ended 30 June 2023[32]. - The increase in gross profit margin was mainly due to cost-cutting measures, including improvements in production efficiency and reduction of raw material costs[30]. Cash Flow and Current Assets - Net current assets as at 30 June 2024 were approximately HK$397.4 million, an increase from approximately HK$339.4 million as at 31 December 2023[34]. - Bank balances and cash as at 30 June 2024 increased by approximately HK$47.7 million or 15.4% to approximately HK$357.6 million compared to approximately HK$309.9 million as at 31 December 2023[34]. - Cash generated from operations for the six-month period was HK$150,823,000, with net cash generated from operating activities amounting to HK$136,875,000, down from HK$187,738,000 in 2023[95]. - The company reported a net increase in cash and cash equivalents of HK$47,495,000, compared to HK$68,790,000 in the same period last year[95]. Future Outlook and Strategic Initiatives - Future outlook remains positive with expectations of continued growth driven by expanding market presence and customer base[27]. - The Group plans to enhance product offerings and invest in new technologies to sustain competitive advantage in the market[27]. - The Group expects continued financial improvement in 2024 and aims to enhance production efficiency across various areas, including production and logistics[44]. - The successful Mattress-in-a-box product line will be promoted not only in the US but also in Europe, with expectations for increased sales and profits[44]. - The Group has entered into several new factory lease contracts in 2024 to expand business operations in Vietnam and the US to meet growing customer demands[44]. Shareholder Information and Corporate Governance - As of June 30, 2024, LAM Chi Fan holds 1,275,906,000 shares, representing approximately 72.91% of the total shareholding[54]. - The total number of shares issued by the company as of June 30, 2024, is 1,750,002,000[54]. - The company has disclosed that all substantial shareholders' interests are recorded in compliance with the Securities and Futures Ordinance[58]. - The company maintains compliance with the Model Code regarding the disclosure of interests and short positions[56]. - The company is committed to high standards of corporate governance to enhance shareholder value[68]. - The audit committee reviewed the unaudited condensed consolidated financial information for the Reporting Period[74]. Employee and Compensation Information - As of June 30, 2024, the employee headcount increased to 3,208 from 2,742 a year earlier, with total staff costs amounting to approximately HK$303.0 million, up from HK$235.5 million[50]. - The Group maintains a competitive remuneration package and various fringe benefits for employees, including medical insurance and training programs[50]. - Key management personnel compensation increased significantly, with salaries and allowances rising to HK$12,484,000 in 2024 from HK$6,761,000 in 2023, representing an increase of approximately 84%[167]. - Total compensation for key management personnel reached HK$12,681,000 in 2024, up from HK$6,923,000 in 2023, indicating an overall increase of approximately 83%[167]. Financial Ratios and Capital Structure - Current ratio as at 30 June 2024 was 130.4%, compared to 126.8% as at 31 December 2023[40]. - Quick ratio as at 30 June 2024 was 93.0%, compared to 86.6% as at 31 December 2023[40]. - Gearing ratio as at 30 June 2024 was 45.8%, down from 48.1% as at 31 December 2023[40]. - Debt to equity ratio as at 30 June 2024 was 8.2%, a decrease from 14.4% as at 31 December 2023[40]. Research and Development - Research and development costs for the period were HK$40,910,000, compared to HK$34,278,000 in the previous year, showing an increase of 19.5%[84]. Inventory and Trade Receivables - The Group's trade receivables, net of allowance for credit losses, increased to HK$600,699,000 as of June 30, 2024, up from HK$542,854,000 at December 31, 2023, reflecting improved sales performance[137]. - The Group's finished goods inventory as of June 30, 2024, was HK$256,759,000, an increase from HK$231,585,000 at December 31, 2023, indicating a strategic buildup of inventory[135]. - The total cost of inventories recognized as expenses in the six-month period ended June 30, 2024, amounted to HK$1,161,730,000, compared to HK$966,186,000 for the same period in 2023, indicating a significant increase[135]. Financial Risks and Management - The Group's activities expose it to various financial risks, including market risk, credit risk, and liquidity risk[104]. - The Group's financial risk management information is not fully included in the interim financial information and should be read in conjunction with the annual financial statements[104].